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Abstract 24 
 Cognitive function below age-matched controls is the hallmark of Alzheimer’s disease. 25 
Brain derived neurotrophic factor is a biochemical molecule that mediates neuronal survival, but 26 
its expression is reduced in Alzheimer’s disease, causing neurodegeneration. Exercise has been 27 
shown to increase Brain-Derived Neurotrophic Factor, which mediates improvements in 28 
cognition in Alzheimer’s patients and slows cognitive decline. Evidence is presented to show 29 
that aerobic exercise is well known to increase serum Brain-Derived Neurotrophic Factor, while 30 
resistance training studies have not yet shown a conclusive effect. Increased Brain-Derived 31 
Neurotrophic Factor from aerobic exercise has been shown to mediate improvements in 32 
hippocampal volume and executive function. No clinical guidelines have been developed for 33 
exercise to improve cognition in Alzheimer’s patients, so clinicians are encouraged to follow the 34 
Canadian Physical Activity guidelines and include both aerobic and resistance training in 35 
exercise programs to achieve maximum cognitive benefits. Exercise prescription is especially 36 
important for those at high risk of developing Alzheimer’s disease, as they will greatly benefit 37 
from the protective effects of Brain-Derived Neurotrophic Factor before converting and exercise 38 
adherence is increased in Alzheimer’s patients if they have found exercise they enjoy.  39 
Keywords: Brain-Derived Neurotrophic Factor, Alzheimer’s disease, aerobic exercise, 40 
resistance training, cognition 41 
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Introduction 47 
As life expectancy increases, the proportion of older adults in the world’s population also 48 
increases, as well as the prevalence of age-related diseases, such as heart disease, diabetes and 49 
dementia. This puts more pressure on research facilities to develop healthy aging strategies and 50 
preventative interventions to prolong the healthy lifespan (Rizvi and Jha 2010). Cognitive 51 
decline is a normal part of the aging process; however, cognitive decline can become more 52 
severe in some older adults than their aged-matched controls, which is the manifestation of 53 
clinical conditions such as mild cognitive impairment (MCI), dementia, and Alzheimer’s disease 54 
(AD). There is an increasing body of evidence that environmental factors can play a role in 55 
healthy cognitive aging (Bherer et al. 2013). Three environmental factors have been described as 56 
being the most important in later life for slowing cognitive decline and preventing against 57 
dementia: an active social network, cognitively stimulating leisure activities, and physical 58 
activity participation (Fratiglioni et al. 2004). Many reviews argue that physical activity is the 59 
most important of these factors for maintaining cognitive function (Bherer et al. 2013; King and 60 
Kitchener 2014).  61 
Cognitive function is mediated by many biochemical factors in the brain, and as the aging 62 
population grows, these molecules become more and more important for understanding the 63 
decline in cognitive health. Brain-Derived Neurotrophic Factor (BDNF) is one of these 64 
molecules, a protein that belongs to the neurotrophins family, which mediates the survival and 65 
maintenance of neurons through binding with the receptor Tyrosine receptor kinase B (TrkB). 66 
Both BDNF and TrkB are decreased in the brains of those with AD (Fumagalli et al. 2006). 67 
Resistance training and aerobic exercise have been shown to affect serum levels of BDNF 68 
(Coehlo et al., 2013), but in different magnitudes and methods, which may be the key to 69 
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understanding how exercise programs mediate improvements in cognitive function. This article 70 
will focus on the role of BDNF in AD and current evidence to show that exercise may be a 71 
valuable treatment for improving cognitive status in older adults through improving the 72 
biochemical environment of the brain.  73 
 74 
BDNF Function in AD 75 
 BDNF and TrkB are produced in the brain and throughout the central and peripheral 76 
nervous systems. In early development, BDNF is produced to differentiate neurons from stem 77 
cells and promote synapse formation. BDNF is continually produced throughout the life span in 78 
low amounts, but even at low concentrations, it is highly effective at preventing neuronal cell 79 
death. When BDNF binds to the TrkB receptor, a complex downstream signalling pathway is 80 
turned on that leads to improved DNA damage repair in neurons and the production of proteins 81 
involved in neuronal survival and plasticity (Marosi and Mattson 2014). BDNF expression is 82 
controlled by many factors, such as sensory stimulation, bioelectric activity, pharmaceuticals, 83 
and a wide array of neurotransmitters (Murer et al. 2001). 84 
 There is a large body of evidence that shows that BDNF expression is decreased in the 85 
brains of AD patients (Murer et al. 2001; Fumagalli et al. 2006). Most of this research is done in 86 
the post-mortem brains of AD patients, as performing a brain biopsy on living patients is not 87 
possible without severe damage to surrounding brain tissue; however, decreased serum BDNF 88 
has also been measured in living patients with both early and late stage AD (Gezen-Ak et al. 89 
2013). A detailed study of the various mRNA transcripts of BDNF showed that three of the 90 
seven identified mRNA transcripts for BDNF were decreased in the parietal cortex of the post-91 
mortem AD brain compared to age-matched controls: transcripts 1 and 3 were decreased two-92 
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fold, while transcript 2 was decreased five-fold compared to controls (Garzon et al. 2004). 93 
Furthermore, in a study by Murer and colleagues (1999), chemical staining done of the brains of 94 
deceased AD patients showed that those neurons that had large neurofibrillary tangles, a major 95 
symptom of AD, did not contain BDNF. Most of the neurons that stained positive for BDNF did 96 
not have the large degrading tangles in them.  97 
 In living patients, there has been evidence that high serum BDNF levels decreases risk 98 
for developing dementia and AD. In a large longitudinal cohort of American adults, it was found 99 
that for each standard-deviation increment increase in BDNF level, the ten-year risk for 100 
developing dementia or AD was decreased by 23% in educated older women (Weinstein et al. 101 
2014). Higher BDNF levels have also been associated with slower cognitive decline in AD 102 
patients after one year follow-up, although further longitudinal studies are needed to corroborate 103 
these findings (Laske et al. 2011).  104 
 105 
BDNF Response to Aerobic Exercise 106 
 There is a large evidence base supporting the positive effect of aerobic exercise on BDNF 107 
concentrations and its mechanism in maintaining cognitive health. A meta-analysis of 18 aerobic 108 
exercise studies showed that BDNF concentrations in peripheral blood supply increased after 109 
aerobic exercise interventions (Dinoff et al. 2016). Similar findings were also reported by Coelho 110 
et al. (2013), Schmolesky et al. (2013), and Huang et al. (2013). These human studies are also 111 
corroborated by many studies using rodent models (Hertzeg et al. 2008). Acute aerobic exercise 112 
was shown to increase BDNF concentrations in both cognitively normal older adults and those 113 
with AD (Coelho et al. 2014).  114 
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 A randomized control trial of cognitively normal community-dwelling older adults by 115 
Leckie et al. (2014) showed that increases in BDNF concentration after aerobic exercise also 116 
mediated improvements in executive function. Those who completed the aerobic exercise 117 
intervention showed improvements in their ability to switch between two tasks as a result of their 118 
increased levels of BDNF. Executive function is the cognitive process used to plan, initiate and 119 
regulate behaviour, and is impaired even in the early stages of AD (Farina et al. 2016). The effect 120 
of exercise derived increases in BDNF on executive function may be important in understanding 121 
the decline in executive function in AD patients and how it can be slowed using aerobic exercise 122 
interventions. 123 
 Another study by Erickson et al. (2011) compared the effects of aerobic exercise and a 124 
control stretching exercise program on serum BDNF concentrations and hippocampal volume in 125 
older adults without previous cognitive impairment. Increases in BDNF concentrations 126 
correlated with increased hippocampal volume only in the aerobic exercise group. The one year 127 
aerobic exercise intervention was able to increase hippocampal volume by 2%, which is 128 
equivalent to reversing the 1-2% deterioration per year normally seen in older adults without 129 
dementia.  130 
 Aerobic exercise has been shown many times to improve multiple aspects of cognition in 131 
both cognitively normal participants and those with AD. Many of these improvements are 132 
mediated by BDNF level increases, which is important for understanding how aerobic exercise 133 
improves cognition as a whole. While many of these studies give promising results, there are still 134 
no defined guidelines for aerobic exercise programs specifically to slow cognitive decline, 135 
whether through maximizing BDNF response or through other exercise mediated improvements.  136 
 137 
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BDNF Response to Resistance Training 138 
Evidence of the relationship between resistance training and BDNF concentrations is less 139 
abundant and conclusive than that for aerobic exercise. A meta-analysis of twelve randomized 140 
control trials using a resistance training intervention showed that BDNF levels in the blood did 141 
not change significantly following the exercise protocols, which ranged in frequency, duration, 142 
time and type (Dinoff et al. 2016). Walsh and colleagues (2016) also found that resistance 143 
training had no effect on basal BDNF concentrations. Blood samples were taken in 20-minute 144 
increments for two hours total, with time zero at the beginning of exercise, as well as under rest 145 
conditions. The blood concentrations of BDNF did transiently increase during exercise, but 146 
dropped back to baseline within two hours, and the rising and falling response of BDNF 147 
concentrations to exercise was the same both before and after the eight-week exercise program.  148 
This program consisted of four sets of eight to ten reps of three different lower body exercises, 149 
increasing from 60% to 80% of 1-repetition maximum (1RM) over an eight-week period. 150 
Alternatively, some resistance training programs have been shown to be effective in 151 
increasing BDNF levels in older adults. In a study by Coelho et al. (2012), older female 152 
participants completed three one-hour training sessions a week for ten weeks, consisting of three 153 
sets of eight reps of various lower body exercises. The weight was set at 50% of participant’s 154 
1RM for the first two weeks and 75% of their 1RM for weeks two through ten, with a re-155 
evaluation of 1RM at weeks five and eight. Participants’ BDNF levels were increased 156 
significantly after the intervention. In another study by Church et al. (2016), participants were 157 
randomized to either a high intensity/low volume (HI) or low intensity/high volume (HV) 158 
resistance exercise protocol. The HI protocol included three to five reps at 90% 1RM, while the 159 
HV protocol included ten to twelve reps at 70% 1RM, each four times a week for eight weeks. 160 
 8 
Blood samples were collected at baseline and on the last day of exercises immediately following 161 
the exercises, as well as thirty and sixty minutes after completion of the exercise session. Plasma 162 
BDNF levels were significantly elevated after both protocols at all three post-exercise time-163 
points.  164 
The effect of resistance training on BDNF levels varies across different experimental 165 
designs and participant samples. Further research on this topic needs to be done before a 166 
conclusive effect can be determined, and if there is a positive effect, which program design is 167 
best for inciting this effect. 168 
 169 
Discussion and Clinical Implications 170 
 The evidence discussed above shows that physical activity participation has many 171 
positive effects on cognition through increasing BDNF concentrations. However, because no 172 
guidelines have been set for exercise specifically to improve cognition, clinicians should focus 173 
on having patients meet the Canadian Physical Activity guidelines for adults 65 and older, which 174 
includes 150 minutes of aerobic activity per week, plus two days of strength training per week 175 
and balance exercises as needed (Canadian Society for Exercise Physiology 2011). As less than 176 
15% of adults aged 60-79 in Canada are meeting these guidelines (Statistics Canada 2015), this 177 
is an important first step for clinicians until special programs to increase cognition are 178 
developed.  179 
 Even though resistance training has not shown conclusive results in increasing BDNF 180 
concentrations, this type of exercise is still important to include in exercise programs for older 181 
adults for many reasons. Resistance training has been shown to improve cognition through 182 
increasing other biochemical factors important for brain health, such as insulin-like growth 183 
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factor-1 (IGF-1) and homocysteine (Liu-Ambrose and Donaldson 2008). Also, exercise 184 
programs that include both aerobic and resistance training exercise combined produce a greater 185 
improvement in cognition than aerobic exercise alone (Colcombe and Kramer 2003). Finally, 186 
strength training exercise programs have been shown to offset the decrease in physical capacity 187 
to do activities of daily living (ADLs) in those with AD and to decrease falls risk, which 188 
improves quality of life for AD patients (Santana-Sosa et al. 2008). Even though resistance 189 
training has not been shown to increase BDNF conclusively, it is still important for increasing 190 
cognition and overall physical health in both cognitively normal older adults and AD patients.  191 
 Exercise prescription is especially important for those at high risk of converting to AD, 192 
such as those with family history of AD or patients with MCI. Once converted to AD, retention 193 
rates of exercise programs vary much more than in programs for cognitively normal older adults 194 
(Yu 2013). Participants with lower scores on cognitive tests, meaning those further along in 195 
cognitive decline, are also more likely to drop out of aerobic exercise programs (McCurry et al. 196 
2010). However, one of the major barriers to exercise cited by AD patients and their caregivers is 197 
the patient’s dislike of structured exercise (Suttanon et al. 2012). If patients can find a type of 198 
exercise they like before converting to AD, participation in exercise may slow their cognitive 199 
decline through increased BDNF, with the additional effect of increasing adherence to the liked 200 
program if they do eventually convert.  201 
 Increasing BDNF concentrations through exercise is an emerging therapy for 202 
neurodegeneration caused by AD. While this relationship has been proven for aerobic exercise, 203 
more research is needed into the effects of strength training and combined programs before 204 
guidelines can be set for exercise prescription. The current Canadian Physical Activity 205 
Guidelines for adults 65 and older should be used for all older patients, but especially those at 206 
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risk for cognitive decline, as the positive relationship between exercise, cognition, and overall 207 
health has been proven in many different mechanisms, not just increased BDNF concentrations. 208 
 209 
Take Home Points 210 
• BDNF is a small protein in the neurotrophins family that improves the growth and 211 
survival of neurons and is decreased in the brains of AD patients. 212 
• BDNF concentrations have been shown to be increased by aerobic exercise, which 213 
mediates improvements in hippocampal volume and executive function. 214 
• Resistance training programs may increase BDNF concentrations, but further research is 215 
needed before a conclusion can be made. 216 
• No specific exercise guidelines have been established yet to improve cognitive function. 217 
The current Canadian Physical Activity Guidelines for older adults should be used for 218 
exercise prescription, as they suggest combined aerobic and resistance training exercise, 219 
which has the greatest positive effect on cognition. 220 
• Exercise prescription is especially important for those at high risk for AD, as increasing 221 
BDNF concentrations may slow their cognitive decline and prior exercise may increase 222 
adherence if they do convert to AD.  223 
 224 
 225 
 226 
 227 
 228 
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